Sunho Biologics, Inc. (02898) published its monthly return as of 31 October 2025. The authorized share capital stands at 200,000,000 ordinary shares, each with a par value of USD 0.0005, totaling USD 100,000. No changes were reported in these figures during the month.

The number of issued shares remains at 156,666,800, with no treasury shares on record. No share options, warrants, convertibles, or other arrangements to issue new shares were disclosed. The document was submitted on 03 November 2025 by the company’s chairman and executive director, underscoring the stability of the equity structure during the reporting period.